“In Vivo Delivery of Nucleic Acid-Formulated Microparticles As a Potential Tolerogenic Vaccine for Type 1 Diabetes ”. The Review of Diabetic Studies , vol. 9, no. 4, Aug. 2023, https://diabeticstudies.org/index.php/RDS/article/view/184.